Biotech News
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2026 financial results will be released before market open on Tuesday, November 10, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Tuesday, November 10, 2026 to discuss the results and recent operational highlights.
